Clinical trials
Tooth, Nonvital trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 19 |
| 2020 | 12 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Unknown status | 32 |
| Recruiting | 9 |
| Not yet recruiting | 6 |
| Active, not recruiting | 5 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 28 |
| Federal University of Pelotas | 4 |
| Istanbul Medipol University Hospital | 4 |
| Ain Shams University | 3 |
| Cukurova University | 2 |
| Hacettepe University | 2 |
| Okan University | 2 |
| Universitat Internacional de Catalunya | 2 |
| University of Nove de Julho | 2 |
| Abant Izzet Baysal University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tooth, Nonvital | 92 |
| Postoperative Pain | 12 |
| Dental Pulp Diseases | 6 |
| Periapical Periodontitis | 6 |
| Dental Caries | 5 |
| Tooth Abnormalities | 3 |
| Tooth Attrition | 3 |
| Periapical Diseases | 2 |
| Tooth Discoloration | 2 |
| Tooth Injuries | 2 |
Trials
Showing 26 to 50 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.